Department of Medicine

Edward Siew, MD, MSCI
January 28, 2020

Protein levels in urine after acute kidney injury predict future loss of kidney function

High levels of protein in a patient’s urine after acute kidney injury is associated with increased risk of kidney disease progression, Vanderbilt researchers report.

By Kelsey Herbers
January 23, 2020

HDL-cholesterol and breast cancer risk

Genetic analyses suggest that high circulating HDL-cholesterol levels may increase breast cancer risk — a surprising finding since increased HDL-cholesterol is thought to be healthy.

By Leigh Macmillan
January 16, 2020

VUMC tops in nation for number of heart transplants performed last year

Vanderbilt University Medical Center tied for first place as the busiest heart transplant program by volume in the United States in 2019.

By Matt Batcheldor
January 16, 2020

Wilkins named CTSA co-principal investigator

Consuelo Wilkins, MD, MSCI, has joined Gordon Bernard, MD, as co-principal investigator of Vanderbilt’s Clinical and Translational Science Award.

By Bill Snyder
January 16, 2020

ACMG issues statement on breast cancer genetic testing

According to a statement on behalf of the American College of Medical Genetics and Genomics, there is insufficient evidence to recommend universal genetic testing for BRCA1/2 alone or in combination with multi-gene panels for all breast cancer patients.

By Tom Wilemon
January 15, 2020

VUMC study to use artificial intelligence to explore suicide risk

Investigators will use computational methods to shed light on suicidal ideation and its relationship to attempted suicide, predict suicidal ideation and suicide attempt using routine electronic health records (EHRs) and explore the genetic underpinnings of both.

By Paul Govern
January 13, 2020

Vanderbilt-led team discovers new genetic disease and defines underlying mechanism

An international research team has discovered a new genetic syndrome caused by mutation of a single gene and named it CATIFA, an acronym for its core symptoms.
By Leigh Macmillan
January 9, 2020

Deadline extended for transplant infectious diseases fellowship

The Division of Infectious Diseases at Vanderbilt University Medical Center is seeking applicants for its new Transplant and Immunocompromised Host Infectious Diseases Fellowship Program.
By Paul Govern
January 9, 2020

Interim directors of Cardiovascular Medicine named

Dan Roden, MD, and Daniel Munoz, have been named interim directors of the Division of Cardiovascular Medicine at Vanderbilt University Medical Center.
By Matt Batcheldor
January 9, 2020

Park named interim Hematology and Oncology director

Ben Ho Park, MD, PhD, has been named interim director of the Division of Hematology and Oncology.
By Tom Wilemon
January 7, 2020

Rothman to succeed Dittus as director of Institute for Medicine and Public Health

Russell Rothman, MD, MPP, professor of Internal Medicine, Pediatrics and Health Policy, Ingram Professor of Integrative and Population Health, and Vice President for Population Health Research, has been named as the new director of the Institute for Medicine and Public Health (IMPH), and Senior Vice President for Population and Public Health.
By John Howser
December 20, 2019

Hepatitis C–positive donors a viable option to expand heart donor pool

Hepatitis C-positive heart donors offer a strategy to safely expand the donor pool and allow more patients to undergo transplant.
By Matt Batcheldor
December 16, 2019

Applications sought for Transplant Infectious Diseases/Immunocompromised Host Fellowship Program

The Division of Infectious Diseases is seeking applicants for its new Transplant Infectious Diseases/Immunocompromised Host (TID/ICH) Fellowship Program.
By Paul Govern
1 … 48 49 50 51 52 … 96